BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
calcium channel activity
,
Influenza
,
Retina
,
Laryngoscope
,
Trichostatin A
,
rs6983267
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Ixabepilone
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Invasive breast adenocarcinomas before Ixabepilone or Paclitaxel treatment
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Managing ixabepilone adverse events with dose reduction.
Locoregional interaction of ixabepilone (ixempra) after breast cancer radiation.
Patupilone and ixabepilone: the effect of a point structural change on the exo-endo conformational p…
Alternative dosing schedules and administration updates for ixabepilone.
Efficacy and safety of ixabepilone in taxane-resistant patients with metastatic breast cancer previo…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Ixabepilone and SBRT For Metastatic Breast Cancer
Ixabepilone and Pemetrexed/Solid Tumors
Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab
Ixabepilone Administered as an Enteric Coated Formulation.
A Study of the Alternative Administration of Ixabepilone and Vinflunine
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ